Spruce Biosciences Inc (SPRB)

Oct 16, 2026

SPRB S-8 & SEC FilingsYahoo Finance - Yahoo! Finance Canada

Oct 16, 2026

Oct 05, 2026

Spruce Biosciences (NasdaqCM:SPRB) Stock Forecast & Analyst Predictions - Simply Wall Street

Oct 05, 2026

Oct 02, 2026

SPRB S-8 & SEC Filings - Yahoo! Finance Canada

Oct 02, 2026

Sep 08, 2026

Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - BioSpace

Sep 08, 2026

Sep 08, 2026

Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire

Sep 08, 2026

Aug 27, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Aug 27, 2026

Aug 27, 2026

Why is Spruce Biosciences stock gaining 4% today? By Investing.com - Investing.com Canada

Aug 27, 2026

Aug 27, 2026

Spruce Biosciences stock gains after analyst backs regulatory progress - Yahoo Finance

Aug 27, 2026

Aug 26, 2026

Spruce Biosciences Announces Launch of MPS3BStudy.com - Yahoo Finance

Aug 26, 2026

Aug 26, 2026

H.C. Wainwright reiterates Spruce Biosciences stock rating on BLA progress By Investing.com - Investing.com UK

Aug 26, 2026

Aug 26, 2026

H.C. Wainwright Maintains Spruce Biosciences(SPRB.US) With Buy Rating, Maintains Target Price $150 - Moomoo

Aug 26, 2026

Aug 24, 2026

Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drug - Fierce Biotech

Aug 24, 2026

Aug 20, 2026

Guggenheim initiates coverage on Spruce Biosciences with Buy rating - scanx.trade

Aug 20, 2026

Aug 18, 2026

Spruce (SPRB) Q2 2026 Earnings: The Bottom-Line Figure Trails Its Comparison in the Latest Session; Reaction Snapshot: Shares Finish 0.14% Lower in the Current UpdateNon-GAAP Earnings - vinanet.vn

Aug 18, 2026

Aug 17, 2026

Guggenheim lowers Spruce Biosciences stock price target to $104 By Investing.com - Investing.com South Africa

Aug 17, 2026

Aug 17, 2026

SPRB Maintained by Guggenheim -- Price Target Lowered to $104 - GuruFocus

Aug 17, 2026

Aug 17, 2026

Guggenheim lowers Spruce Biosciences stock price target to $104 - Investing.com

Aug 17, 2026

Aug 17, 2026

Guggenheim lowers Spruce Biosciences stock price target to $104 By Investing.com - Investing.com Canada

Aug 17, 2026

Aug 17, 2026

Guggenheim lowers Spruce Biosciences stock price target to $104 By Investing.com - Investing.com UK

Aug 17, 2026

Aug 17, 2026

Guggenheim lowers Spruce Biosciences stock price target to $104 - Investing.com

Aug 17, 2026

Aug 16, 2026

Spruce Biosciences (SPRB) Climbs 5.77% to $52.64 as Momentum Builds Toward $55.27 ResistanceBPI Reversal - vinanet.vn

Aug 16, 2026

Aug 15, 2026

Spruce Biosciences (NASDAQ:SPRB) Downgraded to Strong Sell Rating by Wall Street Zen - MarketBeat

Aug 15, 2026

Aug 14, 2026

OrbiMed discloses 7.3% ownership of Spruce Biosciences (SPRB) common stock - Stock Titan

Aug 14, 2026

Aug 14, 2026

Spruce Biosciences | SCHEDULE 13G: Others - Moomoo

Aug 14, 2026

Aug 14, 2026

Spruce Biosciences | SCHEDULE 13G/A: Others - Moomoo

Aug 14, 2026

Aug 14, 2026

Spruce Biosciences (SPRB): ADAR1, Schneeberger disclose 2.5% beneficial stake - Stock Titan

Aug 14, 2026

Aug 14, 2026

Citadel entities and Kenneth Griffin (SPRB) report 1.9% beneficial stake in Spruce - Stock Titan

Aug 14, 2026

Aug 14, 2026

Spruce Biosciences | SCHEDULE 13G: Others - Moomoo

Aug 14, 2026

Aug 14, 2026

Spruce Biosciences (SPRB) sees AWM Investment disclose 5.1% equity stake - Stock Titan

Aug 14, 2026

Aug 13, 2026

SPRB Maintained by Citizens -- Price Target Lowered to $144 - GuruFocus

Aug 13, 2026

Aug 13, 2026

Craig-Hallum Maintains Spruce Biosciences(SPRB.US) With Buy Rating, Maintains Target Price $140 - Moomoo

Aug 13, 2026

Aug 13, 2026

Spruce Biosciences (NASDAQ:SPRB) Given New $144.00 Price Target at Citizens Jmp - MarketBeat

Aug 13, 2026

Aug 13, 2026

Spruce Biosciences (SPRB) Rises 1.42% as Shares Approach Key Resistance at $49.42Extension Target - vinanet.vn

Aug 13, 2026

Aug 13, 2026

Citizens cuts Spruce Biosciences stock price target on share dilution By Investing.com - Investing.com Australia

Aug 13, 2026

Aug 13, 2026

Citizens cuts Spruce Biosciences stock price target on share dilution By Investing.com - Investing.com Nigeria

Aug 13, 2026

Aug 13, 2026

Citizens cuts Spruce Biosciences stock price target on share dilution By Investing.com - Investing.com South Africa

Aug 13, 2026

Aug 13, 2026

Citizens cuts Spruce Biosciences stock price target on share dilution - Investing.com

Aug 13, 2026

Aug 13, 2026

Citizens cuts Spruce Biosciences stock price target on share dilution By Investing.com - Investing.com Canada

Aug 13, 2026

Aug 13, 2026

Citizens cuts Spruce Biosciences stock price target on share dilution By Investing.com - Investing.com India

Aug 13, 2026

Aug 13, 2026

Citizens cuts Spruce Biosciences stock price target on share dilution - Investing.com

Aug 13, 2026

Aug 13, 2026

Spruce Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - biospace.com

Aug 13, 2026

Aug 12, 2026

Spruce Biosciences (NASDAQ:SPRB) Issues Quarterly Earnings Results, Misses Estimates By $0.89 EPS - MarketBeat

Aug 12, 2026

Aug 12, 2026

Spruce Biosciences Q2 Results: EPS Misses Estimate, Losses Widen 91% YoY - scanx.trade

Aug 12, 2026

Aug 12, 2026

Spruce Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 12, 2026

Aug 12, 2026

Form 8K Spruce Biosciences Inc For: 12 August By Investing.com - Investing.com South Africa

Aug 12, 2026

Aug 12, 2026

Form 8K Spruce Biosciences Inc For: 12 August By Investing.com - Investing.com Australia

Aug 12, 2026

Aug 12, 2026

Spruce Biosciences, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 12, 2026

Aug 12, 2026

Spruce Biosciences, Inc. (SPRB) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 12, 2026

Aug 12, 2026

Form 8K Spruce Biosciences Inc For: 12 August By Investing.com - Investing.com Nigeria

Aug 12, 2026

Aug 12, 2026

SPRUCE BIOSCIENCES, INC. 2Q 2026: Net loss $(16.2M), EPS $(6.68) — 10-Q Summary - TradingView

Aug 12, 2026